Clinical Dilemmas in the Management of NSCLC Without Driver Mutations

In this MEDtalk, Maria Silvoniemi, MD, PhD, Turku University Hospital (Tyks) and Chair of the Finnish Lung Cancer Group, discusses key challenges in the management of patients with NSCLC lacking driver mutations. She addresses treatment selection and differentiation, unresolved clinical dilemmas, and persisting data gaps. Dr. Silvoniemi also highlights the most critical evidence gaps related to treatment choices following disease progression, reintroduction of therapy, and other complex clinical scenarios.